Khiron gains German distribution capabilities with new acquisition
Khiron Life Sciences has completed the acquisition of Pharmadrug Production GmbH.
Khiron Life Sciences has completed the acquisition of Pharmadrug Production GmbH.
CEO of UK-based B3 Labs, Marc Burbidge, speaks to Cannabis Wealth about the UK’s Novel Foods process and shares his outlook
The company’s offering will now include cannabis derivatives.
Clever Leaves has officially entered into Israel’s flower market with the first commercial high-quality THC flower export from its cultivation facility in Portugal.
Miles Worne will be Curaleaf International’s first president.
Allied Corp has shipped its second export from the country into Europe, the US and Australia.
B3 Labs has appointed a Chief Operating Officer to drive its growth in the European cannabis market.
Meddcann was given authorisation just one week after the country approved the regulation of cannabis for therapeutic purposes.
The total addressable market for the drug is expected to be nearly $1.7 billion by 2028.
The company now has its products distributed in a number of European countries including the UK, Italy and Denmark.Â
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.